Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Desmopressin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 287,006Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avenacy Launches Desmopressin Acetate Injection In US
    Avenacy Launches Desmopressin Acetate Injection In US

    15 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240415847399/en

    BUSINESSWIRE
    15 Apr 2024
    Share Share
    Gland's Generic Desmopressin Acetate Receives Approval in U.S.
    Gland's Generic Desmopressin Acetate Receives Approval in U.S.

    20 Mar 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216904

    FDA
    20 Mar 2023
    Share Share
    Enforcement Report - Week of December 14, 2022
    Enforcement Report - Week of December 14, 2022

    14 Dec 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-14-2022-47942.pdf

    FDA
    14 Dec 2022
    Share Share
    Enforcement Report - Week of December 7, 2022
    Enforcement Report - Week of December 7, 2022

    07 Dec 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-7-2022-68481.pdf

    FDA
    07 Dec 2022
    Share Share
    Gland's Generic Desmopressin Acetate Receives Approval in the U.S.
    Gland's Generic Desmopressin Acetate Receives Approval in the U.S.

    16 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216922

    FDA
    16 Nov 2022
    Share Share
    ALTURiX Acquires UK rights to desmopressin oral solution
    ALTURiX Acquires UK rights to desmopressin oral solution

    05 Oct 2022

    // PHARMATIMES

    https://www.pharmatimes.com/news/alturix_acquires_uk_rights_to_desmopressin_oral_solution_1456346

    PHARMATIMES
    05 Oct 2022
    Share Share